345311-07-1

Usage

Uses

Used in Pharmaceutical Industry:
1(2H)-Pyrazinecarboxylic acid, 5,6-dihydro-3-methoxy-, phenylmethyl ester is used as an intermediate in the production of various drugs for [application reason]. Its unique chemical structure allows it to be a valuable building block in the synthesis of complex pharmaceutical compounds.
Used in Organic Synthesis:
In the field of organic synthesis, 1(2H)-Pyrazinecarboxylic acid, 5,6-dihydro-3-methoxy-, phenylmethyl ester is used as a building block for creating more complex compounds for [application reason]. Its versatility in chemical reactions makes it a promising candidate for the development of new materials and products in various industrial applications.
Used in Development of New Medications:
1(2H)-Pyrazinecarboxylic acid, 5,6-dihydro-3-methoxy-, phenylmethyl ester has potential applications in the development of new medications for a range of medical conditions. Its unique properties and reactivity make it a valuable compound for exploring novel therapeutic approaches and treatments.

Upstream product

• 420-37-1 trimethoxonium tetrafluoroborate 
• 78818-15-2 4-benzyloxycarbonylpiperazin-2-one 

Downstream Products

• 1202800-41-6 C₁₉H₁₈N₄O₂ 
• 1035216-14-8 2-[3-(3-chloro-4-isopropoxy-phenyl)-[1,2,4]oxadiazol-5-yl]-3-methyl-5,6-dihydro-8H-imidazo[1,2-a]pyrazine-7-carboxylic acid benzyl ester 
• 1035217-20-9 2-iodo-3-methyl-5,6-dihydro-8H-imidazo[1,2-a]pyrazine-7-carboxylic acid benzyl ester 
• 1035217-19-6 3-methyl-5,6-dihydro-8H-imidazo[1,2-a]pyrazine-7-carboxylic acid benzyl ester 

Relevant academic research and scientific papers

QUATERNARY LACTAM COMPOUND AND PHARMACEUTICAL USE THEREOF

A quaternary lactam compound of formula (I). The compound is used in the manufacture of a medicament for the treatment and/or prevention of thrombotic or thromboembolic disorders.

NOVEL OXADIAZOLE COMPOUNDS

Novel oxadiazole compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions as agonists or antagonists of the S1P family of G protein-coupled receptors for treating diseases associated with modulation o

DIKETO AZOLOPIPERIDINES AND AZOLOPIPERAZINES AS ANTI-HIV AGENTS

Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, diketo fused azolopiperidine and azolopiperazine derivatives that possess unique antiviral activity are provided. These compounds are useful the treatment of HIV and AIDS.

NOVEL OXADIAZOLE COMPOUNDS

Novel oxadiazole compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions as agonists or antagonists of the S1P family of G protein-coupled receptors for treating diseases associated with modulation o

Substituted 1,2,3-triazolo[1,5-a]quinazolines for enhancing cognition

The present invention provides a compound of formula (I) in which R1 is generally hydrogen or CF3, R2 is generally hydrogen, W is a cyclic amine, a heterocycle or a group L-Y-X where L-Y is a linking portion and X is generally an aromatic or non-aromatic heterocycle, alkyl or alkylcarbonyl and Z is generally a heterocycle such as 5-methylisoxazol-3-yl, and pharmaceutically acceptable salts thereof for enhancing cognition in conditions such as Alzheimer's Disease, pharmaceutical compositions comprising them, their use for manufacturing medicaments and methods of treatment using them.